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Introduction
 The amount of attention dedicated to the human papillomavirus (HPV) in both the media 
and the medical community over the past six years has been ever increasing.  The development 
and implementation of the HPV vaccine has brought to the surface any number of ramifications.  
As a vaccine against cancer, the implications and importance of this scientific achievement 
cannot be downplayed.  HPV is the most common sexually transmitted infection (STI) and in 
most HPV types, does not cause any noticeable symptoms.  However, in about ten percent of 
cases, HPV can cause genital warts, cervical cancer, anal cancer, penile cancer, or various head 
and neck cancers (“Genital...”, 1). 
 With the first vaccine’s approval in 2006, it was recommended for administration in girls 
between the ages of 11 and 12, with the main focus being on the prevention of cervical cancer 
(Markowitz et al. 16).  Researchers recommended the early age of vaccination because of its 
increased effectiveness and necessity for vaccination before the first sexual encounter.  Critics of 
vaccination immediately responded with critiques about lack of efficacy and safety data, similar 
to the anti-vaccination minority seen with other vaccines.  However, the most striking argument 
was that vaccinating young girls against the vaccine would lead to increased promiscuity (Casper 
& Carpenter, 886).  The recent recommendations by the Advisory Committee on Immunization 
Practices (ACIP) and the American Academy of Pediatrics (AAP) in the past months have 
expanded to include all children (boys and girls) between the ages of 11 and 12, up to age 26 for 
certain demographics of males (“Recommendations,” 1705; “HPV Recommendations,” 604).  
Despite these recommendations, only about one-third of girls and one percent of boys have been 
vaccinated (Knox, 1).  
 To effectively implement the HPV vaccine, it is important to consider what factors or 
barriers may be unique to this vaccine.  First, HPV-related diseases disproportionately affect 
ethnic and sexual minorities.  Race and socioeconomic status have all been linked to higher rates 
of cervical cancer in these females (Hughes et al, 366).  Men who have sex with men (MSM) and 
HIV-positive men are much more likely to develop HPV-related anal cancer than other men 
(“HPV and Men,” 2).  It is important to consider vaccine access and acceptance within these 
populations to determine the uptake and effectiveness of the vaccine.
 Secondly, since the vaccination is recommended for implementation during adolescence, 
parents and physicians play a large role in seeking and providing the vaccine for their children.  
Many parents seek answers to questions on the internet, instead of from providers, making them 
more vulnerable for misinformation.  Demographic factors also influence which parents are more 
likely to have their children vaccinated (Downs et al., 1595).  Support for mandated vaccinations 
is low because it decreases parental autonomy (Ferris et al., 220).  Patients who receive a strong 
physician recommendation are more likely to receive the vaccination (Rosenthal, et al., 893; 
Vadaparampil et al., 8640).  Physicians, who influence the delivery of the vaccine to the majority  
of targeted patients, deserve special attention.
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 Finally, the sexual nature of the disease brings with it a number of factors to influence 
care.  Stigma associated with STIs has been shown to influence patients seeking treatment and 
care (Lichtenstein, 2435).  It has also been shown that increased knowledge about the disease 
transmission may negatively influence the patient experience (Waller, 157).  Some 13% of girls 
in the US are sexually active by age fifteen (Charo, 1907), which brings to light the need of 
increased awareness and education among children and parents.  
Demographic Factors
 Cervical cancer is the second most common cancer in women, with 493,000 new cases 
annually worldwide, but with only about 12,000 cases occurring in the United States.  With some 
225,000 deaths from cervical cancer, about 80% of all deaths are in developing countries 
(“Genital,” 2; Casper & Carpenter, 888).  African American women are 50% more likely to be 
diagnosed with cervical cancer, and twice as likely to die from cervical cancer as white women.  
Also, women who live in rural areas have higher cervical cancer death rates than those women in 
urban areas (Cates et al., 93).  Pap tests are the best way to screen for cervical cancer in women.  
With early detection and appropriate treatment, cervical cancer mortality can be greatly reduced. 
The Pap test allows providers to remove abnormal cells before they advance to further stages of 
cervical cancer (“Genital,” 4).    
 Among cases of cervical cancers in the US, most deadly cases can be found based on 
ethnicity or socioeconomic status (Casper & Carpenter, 888).  It is thus important to consider 
what factors influence patients seeking preventative care.  In a sample of minority women living 
in public housing, approximately 33% had not received a cervical cancer screening in at least 
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two years.  Some factors associated with this lack of seeking care were both education level and 
fluency in English.  Women who had some type of healthcare coverage were two times more 
likely to have had a screening, likely because of their easier access to a physician (Bazargan et 
al., 469-72).  The lack of access to pap testing in these minority populations highlights that this 
population needs to be specifically targeted for administration of the HPV vaccine as an 
alternative prevention strategy.  However, the barriers that existed for pap screening will likely 
be similar for access to the HPV vaccine, thus only furthering the disparity (Brewer & Fazekas, 
113).   
 Knowledge and understanding of HPV and health information is an important factor in 
determining whether patients seek the vaccine and is a factor in health disparities (Hughes et. al, 
264).  There are many disparities in both knowledge and acceptance of HPV and the vaccine in 
southern women.  More than 25% fewer black women had heard of HPV and also scored lower 
in HPV knowledge than white women.  Although knowledge of the vaccine was very low in both 
ethnic rural populations, black women were more likely to not want to vaccinate their daughters 
before the age of 17 for HPV (Cates et al., 94-6).  In a similar study of caregivers for young 
females, much the same was found in terms of health knowledge disparities.  While 82% of all 
caregivers had heard of the HPV vaccine, African American and other non-white races, less 
educated, and those of a lower socioeconomic status were much more likely to be unaware of 
HPV.  Only about two-thirds of questions about HPV were answered correctly on average 
(Hughes et al., 366-70).  It is important to tailor vaccine education to both rural and ethnic 
populations to ensure HPV vaccine uptake in these vulnerable populations.
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 Specifically in the African American community, there is a difficult dynamic that exists 
between medical professionals and patients.  Particularly, many in the South use the example of 
the Tuskegee experiment, which denied treatment for STI-infected males, as a motivation for 
their avoidance of care.  African Americans are also distrustful of the medical statistics that point 
to the idea that they have the highest rates of STI infection (Lichtenstein, 2440).  The belief that 
they as African Americans are targets of the medical establishment only serves to prevent 
vaccination and testing, furthering the infection rate of this population.
 Anal HPV infection is very common in the MSM community, in that 60% of all 
individuals are infected, and 90% of all HIV-positive individuals are infected (Reiter et al., 197).  
Since vaccination of male adolescents has only recently been suggested by the ACIP and AAP, 
very little data is available about actual uptake of the vaccine among males.  However, since 
MSM and HIV-infected persons are at a greater risk for being affected by HPV-related diseases, 
acceptability and knowledge in this population has been studied.  Anal cancer in both men and 
women can be screened for, using a pap test, similar to those used for cervical cancer screening 
in women (“HPV and Men,” 2-3).  However, many barriers exist that prevent men at high risk 
from seeking screening and treatment.  Mainly, “anal cancer screening alone identifies men as 
first, engaging in receptive anal intercourse, and second, as being gay” (Newman et al., 332).  
Men can be hesitant for fear of reactions from health care providers and the possibility of 
negative reactions.  Men, particularly in the Latino community, are reluctant to seek any type of 
preventative healthcare, and only seek treatment once symptoms have manifested (Newman et 
al., 334).   
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 Current knowledge of the vaccine and virus risks are important to consider in 
determining uptake of the vaccine.  In a 2011 study, although most men had heard about HPV, 
only about 25% knew that the vaccine was also available for males.  Also, many men were 
unaware about the health implications for men, including genital warts and anal, oral, or penile 
cancer (Wheldon, 8063; Reiter et al, 198).  Since most MSM are not open about their sexual 
interests before their first sexual encounter, the strategy to target all males for vaccination is 
extremely important (Reiter et al, 201).
Parents, Providers, and Vaccines
 Since the target demographics for vaccination are young adolescents, in the absence of a 
mandated vaccination, parental knowledge and acceptance of the vaccine will be critical for 
successful implementation (Zimet, S19).  Studies considering vaccine acceptability among 
parents have spread light on different factors that parents consider important.  There are a 
number of reasons why parents may choose not to vaccinate children against a disease.  The lack 
of vaccinations can be related to socioeconomic factors or objections for religious or moral 
issues (Downs et al.,1595-6).  Daughters who are vaccinated tend to be older, and have parents 
who have positive attitudes toward vaccination and more HPV specific knowledge (Gerend et al., 
530).  Since most parents are unaware of the prevalence of HPV, acceptance of the vaccine is 
much lower than ideal levels for increased community protection (Ferris et al., 227).
 By far, one of the most significant factors important to the response of parents to the HPV 
vaccine concerns the location of information received.  Many parents have received basic 
knowledge and awareness of the HPV vaccine as a result of pharmaceutical advertisements 
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(Hughes et. al, 367).  This is favorable in the sense that the information being received about the 
vaccine is likely positive.  On the other hand, parents also receive their information from online 
sources.  The increase in access to medical information by some has allowed many to question 
medical knowledge openly (Leask et al., 7238).  Some parents have a lack of basic understanding 
of the mechanisms of vaccines (Downs et al., 1604).  Although CDC fact sheets do exist, many 
parents seek more information online instead of consulting their physicians.  As a result, parents 
are more vulnerable to misinformation and may be unaware when this information is presented.  
Parents researching about vaccination within simple web searches are likely to encounter anti-
vaccination websites (Zimet, S21).  These groups focus less on generic factual information, and 
more on broad arguments resulting in an emotional response (Leask et al., 7238).  This can 
include information about medical controversies or capitalistic motivations, and foster negative 
attitudes of those already suspicious of the government and the medical establishment.  
 Physicians play extremely important roles in ensuring the behavior and activities of their 
patients.  Acceptance of vaccines in general is linked to a physician’s recommendation.  A 
physician recommendation has been shown to be the strongest predictor of vaccination among 
older adolescents (Rosenthal et al., 893).  Adolescent health care providers include family 
practitioners, pediatricians, and obstetricians/gynecologists (OB/GYNs).  Pediatricians are much 
more likely to recommend vaccination.  Among all these specialties, physicians recommended 
the vaccine to early adolescents much less than to older adolescents, even though vaccination 
recommendations specify early adolescents as targets.  Of most interest is that those physicians 
who participated in the Vaccines for Children (VFC) program, providing the vaccine at no cost to 
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Medicaid patients, were much more likely to recommend the vaccine, likely because of better 
funding and availability of the vaccine (Vadaparampil et al., 8636-38).  
 Despite the importance of physicians educating parents, this may not have as strong a 
function as expected.  Even with the receipt of information about HPV and the HPV vaccine, the 
likelihood of parents to vaccinate children did not change before and after information receipt.  
This is significant because parental negative attitudes toward vaccination may be based on 
feelings and personal views, rather than factual information (Dempsey et al., 1491).
Disease and Sexual Stigma
 The HPV vaccine represents an effective prevention strategy for a contagious, sexually 
transmitted disease.  By eliminating the “contagion,” the vaccine removes the danger, risk, and 
vulnerability of those at risk.  At the same time, the vaccine introduces itself into a very private 
and personal area of life which is not often discussed.  The implementation of the vaccine has 
served to “transform social relations,” forcing the discussion of medical advancement to occur 
within the context of social change and expectations (Casper & Carpenter, 887).
 The United States has some of the highest rates of STIs among all other developed 
nations (Lichtenstein, 2453).  One of the most important factors associated with this is the stigma 
that is attached to sexual behavior and its consequences.  Stigma is “an attribute or label that sets 
a person apart from others and links the labeled person to undesirable 
characteristics” (Fortenberry qtd Lichtenstein, 2437).  Stigma serves as a significant deterrent in 
terms of patients seeking treatment.  The study by Waller et al., sought to study the effect of STI 
knowledge on the patient experience.  Patients who were HPV infected and knew HPV was an 
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STI had higher levels of stigma and shame.  However, those who were also told about the high 
prevalence of HPV were shown to have lower levels of stigma and shame (157-8).  Without 
active HPV education, the knowledge of HPV as an STI may serve as a barrier for vaccination 
because this would serve as an acknowledgment of sexual activity.  
 The sexual nature of the vaccine also creates different reactions based on gender.  
Although many were worried about the idea of immunizing young girls for an STI, the reaction 
has not been the same for immunization of boys (Knox, 1-2).  In either gender, the feeling is that 
by administering an STI vaccine to young adolescents, they may be more likely to engage in 
sexual activity because of the decreased perceived risk and fear.  Of those parents who did not 
want to vaccinate a female child, the main concern was sexual activity increasing (Herzog et al., 
S6).  The gender difference is also seen with access to treatment for other STIs.  Although 
women were judged and blamed when they sought treatment, male sexual behavior was viewed 
as expected and normal.  The effect of gender and sexual activity affects the willingness of 
patients to seek vaccination and information (Lichtenstein, 2438-9).
Recommendations and Conclusions
 The HPV vaccine is still a relatively new treatment that health care providers are trying to 
successfully implement.  The sexual and ethnic minorities disproportionately affected by the 
infection are equally affected by lack of knowledge about HPV (Hughes et al., 363-4).  Focusing 
only on educating parents may not be enough to influence parental attitudes about vaccinations.  
One of the strongest factors may indeed be provider recommendation to increase vaccination.  
The sexual nature of HPV involves having to address differences in expectations of boys and 
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girls, and appropriate behavior by age.  Much still needs to be studied to determine how to 
continue to increase awareness and uptake of the vaccine.  With the still recent recommendation 
of vaccination of boys, public reactions and opinions are still unknown and will likely change.
 To combat the influence of anti-vaccination messages, it will be useful for parents to be 
informed by their physicians upfront about the risks of vaccination.  If properly educated about 
the low risks, surprising stories about the side effects of vaccination will have less of an effect 
(Leask et al., 7248).  Also, framing the vaccine as disease prevention against genital warts and 
cervical cancer may increase vaccination rates.  Since genital warts are a more visible 
consequence of HPV, parents may be more willing to protect children against a visible indicator 
of an STI to protect them from the associated stigma (Dempsey et al., 1492).  
 To consider what might be the most effective strategy for vaccine implementation among 
adolescents, it is useful to consider the implementation of the Hepatitis B vaccine.  While only 
about 33% of adolescent girls are currently vaccinated for HPV, 96% are vaccinated for Hepatitis 
B, even though it is usually transmitted via sexual contact as well.  The importance here is that 
the Hepatitis B vaccine is mandated for students before entrance to middle school (Ferris et al., 
220; Knox, 1).  Once mandated, large scale school vaccinations programs were aimed at 
vaccinating those who had missed vaccination at an earlier age.  By mandating the vaccine for 
middle school entry, social and economic disparities in terms of access to the vaccine were 
eliminated (Averhoff, et al., 982-3; Stewart, 801).
 The legal argument against mandating the HPV vaccine is that HPV can only be 
transmitted via intimate contact, as opposed to casual contact via blood like hepatitis B (Stewart, 
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802-3).  However, including an opt-out system will allow parents who have an objection to 
address their concerns, while allowing the children of those not against the vaccine to easily 
receive the vaccine as part of school vaccination programs without parental action (Charo, 
1906-7).
 Also, the idea that vaccination against the STI is against abstinence only teachings in 
schools should only be used to highlight the ineffectiveness of abstinence only approaches.  
Since 43% of girls are sexually experienced by age 17, school based STI preventative treatments 
need to be seriously considered.  Also, the idea that vaccination alone encourages sexual activity 
completely ignores all other threats such as pregnancy and HIV/AIDS (Charo, 1907).  Teenage 
sexual activity is a fact in the United States and cannot be ignored.  
 The argument has been made that HPV is being misrepresented by the media and 
pharmaceutical companies as an immediate threat and epidemic in the west, while an epidemic 
does not exist (Connell & Hunt, 64).  HPV is a deadly and, until recently, silent epidemic among 
some of the most vulnerable populations in the United States.  To effectively reach these 
populations, all must be targeted for vaccination.  To recommend the vaccine at a young age to 
only those at an increased risk would not work because some may not have the ability to be 
identified in the risk group, such as homosexual boys or sexually active boys or girls (Humisten 
& Rosenthal, S136).  The HPV vaccine is a significant advancement in medical technology.  The 
various factors affecting the acceptance and uptake of the vaccine are important to consider, 
address, and continue to study in order to completely address the barriers to vaccination. 
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